Definitive Contract 75D30119C06574

Award Date 9/30/19
Potential Completion Date 9/29/21
Potential Value $989K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jacobus, PA 17407, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $179,800.00 firm fixed price purchase order contract to Aptagen LLC, a limited liability company, for aptamer development services. The contract, which does not have a set-aside designation, is scheduled for completion on September 19, 2023. Through this contract, Aptagen LLC will provide services related to the development of aptamers, which are synthetic antibodies, including for HIV...
This contract was awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) to Aptagen LLC, a small business contractor, to conduct research to find human carriers of taeniasis in order to prevent neurocysticercosis-associated epilepsy. The contract, valued at $126,680, was issued under the CDC's Small Business Innovative Research (SBIR) program and is a Firm Fixed Price Purchase Order. Aptagen LLC, a limited liability company with over 30 years...
Aptagen LLC was awarded a firm fixed price purchase order valued at two hundred fourteen thousand seven hundred eighty dollars ($214,780) by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract is for the development of aptamers, or synthetic antibodies, for HIV integrase through September 21, 2022. No set-aside designation was used for this procurement. Aptagen will perform the work out of its Jacobus, Pennsylvania facility. As a...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase 1 contract to Lynntech Inc., a small business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis-associated epilepsy. The firm fixed-price contract has a potential value of $149,875 and was awarded on September 17, 2018, with a completion date of September 16, 2019. The contract was set aside for small businesses.
This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Kephera Diagnostics LLC, a small business. The contract is for the development of diagnostics to detect taeniasis, a parasitic infection, in order to prevent neurocysticercosis and associated epilepsy. The award amount is $150,000.00 and the contract has a firm fixed price pricing type. The contract was set aside...
This is a $125,000.04 firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for aptamer development services, and does not have a set-aside designation. Through prior contracts and grants, Base Pair Biotechnologies has provided research and development services related to...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $208,399.84 potential value contract to Advanced Technologies And Laboratories (Atl) International, Inc. under a Blanket Purchase Agreement call for scientific professional engineering support services. The prime contractor, a division of Planned Systems International Inc. which does business as Psi, will provide the requested products and services to the CDC at the specified place of...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $1.2 million firm fixed price purchase order to Aegis Sciences Corporation of Nashville, Tennessee for genomic sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing under its Aegis Analytical Laboratories division. The contract runs from March 1, 2021 through April 15, 2021 to support genomic sequencing efforts at the CDC, likely related to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $147,500 purchase order to Life Technologies Corporation for custom TaqMan array cards to be delivered to their facility in Grand Island, New York. As the prime contractor, Life Technologies will provide the requested products for use in CDC's disease prevention and health promotion efforts. The firm fixed price contract runs from August 31, 2023 through October 30, 2023. Thermo Electron...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $989,300.00 Firm Fixed Price Definitive Contract to Aptagen LLC, a for-profit limited liability company, to provide SBIR Phase II funding for finding human carriers of taeniasis to prevent neurocysticercosis associated epilepsy. The contract, which does not have a set-aside designation, was awarded on September 30, 2019 with a completion date of September 29, 2021. Aptagen LLC has over 30 years of experience in aptamer development and has previously provided aptamer development services and developed aptamers for HIV integrase to the Centers for Disease Control and Prevention under prime federal contract awards.

Generated 3/23/24, 5:21 PM